TELA Bio Launches Post Market Study Of OviTex In Hernia Surgery 2021-05-19T13:16:36-04:00May 19th, 2021| share this article! , Benzinga Staff Writer May 19, 2021 9:16am 114 Read More share this article! Related Posts Chubb Limited (NYSE: CB) Surges On Dividend Increase And Berkshire Hathaway Investment – Chubb (NYSE:CB) May 17th, 2024 Wall Street Favorites: 3 Retail Stocks With Strong Buy Ratings for May 2024 May 17th, 2024 Google DeepMind CEO: ‘This Is the Next $100 Billion AI Business’ May 17th, 2024 The Dow hit a new record. What it tells us about the economy, what it means for 401(k)s. May 17th, 2024